TXG R&D to Revenue
10X Genomics Inc Class A · R&D to Revenue
TXG R&D to Revenue
Latest reported37.12%period ending
TXG FY R&D/Revenue (45.25% → 37.12%)
Latest values, visible window
High-resolution chart · PNG
TXG r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 37.1225% | |
| 43.3373% | |
| 43.6916% | |
| 51.4451% | |
| 43.1715% | |
| 41.2839% | |
| 33.794% | |
| 32.4899% | |
| 45.2472% |